Tobacco Documents Online

t '3rd class' sought to curb abuse The board of trustees of the New Ierse.• Pharmaceutical Assn has l,rupaj,ecl that nie(licine:, sul)iect tto akt:e tc~ 1>ut in a"thircl class", sold .1nly by pharmacist". ti1e lut>l)«sal was tnade in re- ;Ircm:e to a call by New -lerse\ G)v. Cahill for increase(I control t)ver the salr uf aUnsect pru<Iucts. According to the assor.iatinn su;*- ;*e~tinn, "the 'thirrl class' wotlld re- nu~ve such lxrtentially ai>tlsai)le ilieo-licine as cough syru1,.,, stulnacll remedies. anti-natlseant.,, cidcl 1>rel,- ara*,ic,na, tran(litilizers, and elixir> high in alcuholic content fr<<ni the cla,:' comprising non-lrre- •cril,t)f,n as cli>tinct fr()I» the 'tirst cla"" "Ohich cclrlstitntes medi- c<ctif,n obtainal,le only nn a cIc ct<rr'~, Insufficient: lt NvaN relmrtrcl at the lruarrl uf tru~,tee,, nteetin,- that five mmmicil,alitie5 irl New lerse\ 's •lliclrlle,ex Cntlnty have enacterl r>r- {li;iance, l)anning u1,en cli;l,lay of certain (lrtlg-), and Itrc,ltii>itinl; saleti to tninors. Alexanrier ,ll. 1',ell• a menlber c,f the lmar(t of trnstees, held that these zxle.a,qire, are instifhcient, ancl that ntore expert supervi,tiirr,lf is retlttrretx anrl more experiencecl enforcement i,, nee(lecl than that l,ruviclect h%• local police ctel,artments." \leamdhile, the }:iwani. Club of New Nrunswick has actuptecl a reso- lution H•hich asks that "comtrul ancl res}wnsibility for sale of stuh drng,~, a; dextrc,-nlethr,rl,han, hella(lnna alkaloids, 1>henobarl)ital. antihista- mines and 11rr,clucts containing eth\•1 alcohol in 12~j~ concentration or over i)e placeci w•ith tile state boarel (if hharnlacy. The }:iK•anian5 further ttr{{e<l that sale anrl (lisl,ensing of the (lrugs be restricte(l to l,hartliacist5, that snch 1,rucitut5 bear a package iclentifica- tiun as to the pharniac}• source, ancl sale be Iinlite(l to lrers<ms 21 or ~~il~ler, and then' rnil~~ fryr valirl ase"i News • 37 INDUSTRY GRAMS Convenience, economy and patient acceptance are good reasons for producing combination drugs, provided each ingredient clearly enhances the efficacy or safety of the item, an FDA advisory panel has stated. The panel report comes on the heels of an intensive FDA drive to rid the marketplace of fixed combination drug products which the NAS/NRC efficacystudyhas declared to be ineffective.  EXECUTIVE CHANGES: At 3M: Harry Heltzer to chairman and chief exec, succeeding retir- ing Bert Cross. Raymond Herzog becomes pres. •.. Noxell: George Barbee to new prod mgr; Roger Yeager to Noxzema and Thera-Blem lines prod mgr . . . Allergan: Roy Richardson to genl mgr, G. S. Herbert Labs div ..• LaVerdiere's Su er Drug Stores: Reginald LaVerdiere to pres and genl mgr succeeding Evariste LaVerdiere, who becomes board chairman. Paul LaVerdiere to exec v.p. . . . Tannehill Pharmaceuticals: Hank Burdick to natl sales dir for Health-Rite vitamin and food products; Robert Gaver to mktg dir for Tannehill Pharmaceuticals vitamins and specialties . . . Clinical studies on an experimental drug may not begin until 30 days after the drug's sponsor has submitted an investigational drug application to FDA, under a new regulation just adopted by the agency. Purpose of the rule is to "assure that patients are not ex- posed to unwarranted risks" by resolving safety questions in advance of clinical trials."  The Commerce Dept has proposed a plan to limit OTC drug package sizes to 10-tablet or 10-oz increments in an effort to curb package proliferation of such products. A number of drug field organizations have been invited to comment on the plan. . Carter-Wallace has moved to prevent a num- ber of drug firms from importing bulk meproba- mate for resale in finished dosage forms. Un- der a 1962 antitrust consent judgment, Carter- Wallace is obliged to sell bulk meprobamate to any qualified domestic company.